NOX1 and biliary liver cirrhosis: This molecule is a NOX1/4 inhibitor developed to prevent oxidative stress and fibrosis in multiple diseases including primary idiopathic fibrosis, primary biliary cholangitis, and diabetic nephropathy [67].